ASX:OCCPharmaceuticals, Biotechnology & Life SciencesBiotechnology
Orthocell Ltd
$0.810
+$0.015 (+1.89%)
Day Range
$0.800 – $0.810
52 Week Range
$0.700 – $1.600
Volume
59.24K
Avg Volume (10D)
229.43K
Market Cap
$220.59M
Price Chart
Market Statistics
Open$0.805
Previous Close$0.795
Day High$0.810
Day Low$0.800
52 Week High$1.600
52 Week Low$0.700
Valuation
Market Cap220.59M
Shares Outstanding272.33M
Price to Book5.27
Trading Activity
Volume59.24K
Value Traded47.68K
Bid$0.800 × 1,085
Ask$0.810 × 2,390
Performance
1 Day9.59%
5 Day9.59%
13 Week-2.44%
52 Week-34.69%
YTD-26.27%
Technical Indicators
RSI (14)63.55
50-Day SMA$0.755
200-Day SMA$0.893
Latest News
Biotechnology
Orthocell Appoints MediTime as Thai Distributor for Remplir Nerve Repair
Orthocell names MediTime exclusive Thai distributor for Remplir nerve repair, taps US$84m market; Thai FDA CY25 approval; $48m cash, no debt.
Biotechnology
Orthocell Secures Access to 221 US Military & VA Medical Centres for Remplir
Orthocell wins access to 221 US DoD/VA centres for Remplir, a major US market expansion as HY26 revenue hits A$6.2m and cash sits at A$49.4m.
Biotechnology
Orthocell's Remplir Device Used in 23 Ukrainian Soldier Surgeries, Validating Field Utility
Orthocell's Remplir validated after 23 Ukrainian surgeries, boosting defence-market traction and global expansion; HY26 revenue +49%, cash ~A$49m.
Biotechnology
Orthocell Appoints Exclusive Remplir Distributor Ahead of UK Rollout
Orthocell names LEDA Orthopaedics exclusive UK distributor for Remplir ahead of regulatory approval, signaling rapid UK rollout and market prep.